The gut-skin axis describes the bidirectional communication between the digestive system and the skin, involving shared immune pathways, microbial metabolites, and systemic inflammatory signals. Published research documents this connection across skin conditions including acne, eczema, and psoriasis. Gut dysbiosis has been observed alongside these conditions, with compromised gut barrier integrity and systemic inflammation as proposed mechanisms. Supporting digestive health daily is the evidence-consistent approach to this connection†.

Probiotics' primary validated role is supporting digestive and immune health†, their FDA structure-function purpose. The gut-skin axis is the scientific basis for a possible connection; a healthy gut microbiome may have systemic relevance for skin well+being. No probiotic product carries an FDA-approved skin health claim, and research in this area is ongoing. Digestive health support remains the most research-consistent starting point for this wellness goal.

The most-studied skin conditions in gut-skin axis research are acne, atopic dermatitis (eczema), and psoriasis. All three are inflammatory conditions, and systemic inflammation, potentially influenced by gut dysbiosis, is the proposed shared mechanism. Published research documents study across all three conditions, with results that are promising but strain-specific and still emerging. Consulting a healthcare professional or dermatologist is appropriate for managing any skin condition.

Research consistently links lower gut microbial diversity to higher systemic inflammation, a key pathway in the gut-skin axis. A diverse microbiome produces more SCFAs, supports stronger gut barrier integrity, and regulates immune responses more effectively. People with inflammatory skin conditions have been observed to show lower gut microbial diversity in published research. Diet, including fiber, fermented foods, and plant variety, is the primary driver of diversity.

Bio-K+'s exclusive 3-strain formula, Lacticaseibacillus casei LBC80R®, Lacticaseibacillus rhamnosus CLR2®, and Lactobacillus acidophilus CL1285®, is backed by 16 published clinical trials. Bio-K+ draws on more than 30 years of probiotic research and 45+ peer-reviewed publications on gut health outcomes. This formula promotes, supports or maintains digestive and immune health†, available in drinkable (dairy and vegan, 50B CFU) and capsule formats, with CFU guaranteed until best before date using targeted-release technology.

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.